Gastrointestinal dysfunction is associated with mortality in severe burn patients: a 10-year retrospective observational study from South China

Table 6 Subgroup analysis of the association between GI dysfunction and clinical outcomes in patients with severe burns

Clinical outcome	Victims^*	Controls^**	P-value
GI haemorrhage or ulcer (n_victims = 45, n_controls = 283)
90-day mortality [n(%)]	34 (75.6)	42 (14.8)	< 0.001
MODS [n(%)]	35 (77.8)	52 (18.4)	< 0.001
Sepsis [n(%)]	28 (62.2)	79 (27.9)	< 0.001
Length of ICU stay [d, M (Q₁, Q₃)]	4 (0, 10)	0 (0, 3)	< 0.001
Nausea/vomiting (n_victims = 33, n_controls = 295)
90-day mortality [n(%)]	15 (45.5)	61 (20.7)	0.004
MODS [n(%)]	15 (45.5)	72 (24.4)	0.013
Sepsis [n(%)]	19 (57.6)	88 (29.8)	0.003
Length of ICU stay [d, M (Q₁, Q₃)]	2 (0, 10)	0 (0, 3)	0.003
Constipation (n_victims = 64, n_controls = 264)
90-day mortality [n(%)]	20 (31.3)	56 (21.2)	0.099
MODS [n(%)]	19 (29.7)	68 (25.8)	0.530
Sepsis [n(%)]	21 (32.8)	86 (32.6)	0.971
Length of ICU stay [d, M (Q₁, Q₃)]	0 (0, 5)	0 (0, 4)	0.590
Abdominal distension (n_victims = 27, n_controls = 301)
90-day mortality [n(%)]	18 (66.7)	58 (19.3)	< 0.001
MODS [n(%)]	11 (40.7)	76 (25.2)	0.109
Sepsis [n(%)]	13 (48.1)	94 (31.2)	0.087
Length of ICU stay [d, M (Q₁, Q₃)]	0 (0, 10)	0 (0, 4)	0.115

GI gastrointestinal, MODS multiple organ dysfunction syndrome, ICU intensive care unit
^*Victims refer to patients suffering the corresponding subsymptoms of GI dysfunction
^**Controls refer to the remaining patients other than the patients with the specified GI dysfunction subsymptoms; they may suffer other subsymptoms of GI dysfunction

ISSN: 2054-9369